Automated Compounding Devices Market Expansion 2024-2033: Growth Drivers and Dynamics

The automated compounding devices global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Automated Compounding Devices Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The automated compounding devices market size has grown strongly in recent years. It will grow from $2.2 billion in 2023 to $2.36 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, an aging population, the expansion of healthcare infrastructure, regulatory requirements, and increasing medication errors.

The automated compounding devices market size is expected to see strong growth in the next few years. It will grow to $3.12 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to rising cancer prevalence, global healthcare expansion, increased focus on patient safety, regulatory support, and an and an increasing focus on sustainability. Major trends in the forecast period include telemedicine, remote healthcare, advancements in artificial intelligence, healthcare digitalization, and real-time monitoring.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

Scope Of Automated Compounding Devices Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Automated Compounding Devices Market Overview

Market Drivers –
The increasing number of personalized medicines is expected to fuel the growth of the automated compounding devices market going forward. Personalized medicine refers to a medical approach that tailors healthcare decisions, practices, interventions, and treatments to the individual characteristics of each patient. The increasing number of personalized medicines is due to a better understanding of genetics, patient-specific data, and regulatory support. Automated compounding devices (ACDs) play a crucial role in the field of personalized medicine by enabling the precise and accurate preparation of custom medication formulations tailored to individual patient needs. These devices automate the process of combining various pharmaceutical ingredients in specific proportions, which is essential for creating personalized treatments. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the increasing number of personalized medicines is driving the growth of the automated compounding devices market.

Market Trends –
Major companies operating in the automated compounding device market are focusing on reducing medication errors and improving patient safety with advanced technologies, such as robotic compounding technology, to gain enhanced customer trust, regulatory compliance, and a competitive advantage. Robotic compounding technology automates the precise preparation and mixing of pharmaceutical compounds using advanced robotic systems, enhancing accuracy, efficiency, and safety in medication preparation. For instance, in March 2022, Omnicell Inc., a US-based healthcare technology company, launched the IVX Station, a new automated compounding device. This innovative solution aims to expand access to IV robotic technology in the broader market, enhancing patient safety, accuracy, cost efficiency, supply chain management, and regulatory compliance. The IVX Station offers three times faster throughput than current IV robotic systems, incorporates a highly reliable design to minimize downtime, and maintains a compact footprint suitable for pharmacy operations.

The automated compounding devices market covered in this report is segmented –

1) By Component: Automated Compounding Systems Equipment, Automated Compounding Systems Software
2) By Product Type: Intravenous Compounding Systems, Oral Compounding Systems, Total Parenteral Nutrition (TPN) Compounding Systems
3) By Mode Of Operation: Fully Automated Compounding Systems, Semi-Automated Compounding Systems
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Get an inside scoop of the automated compounding devices market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18231&type=smp

Regional Insights –
North America was the largest region in the automated compounding devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the automated compounding devices market are McKesson Corporation, Amerisource Bergen Corporation, Medtronic PLC, Becton Dickinson and Company, Baxter International Inc, B. Braun Melsungen AG, Fresenius Kabi AG, Grifols International S.A., Terumo Corporation, ICU Medical Inc., Omnicell Inc., Tecan Group Ltd., Cantel Medical Corp., Fagron N.V., Swisslog Healthcare, ScriptPro LLC, PharMEDium Services LLC, Loccioni Group S.p.A., ARxIUM Inc., Codonics Inc., Apexus Inc., Equashield LLC, Yuyama Mfg Co. Ltd., Shanghai Weibond Technology Co. Ltd., Quirem Medical B.V

Table of Contents

1. Executive Summary
2. Automated Compounding Devices Market Report Structure
3. Automated Compounding Devices Market Trends And Strategies
4. Automated Compounding Devices Market – Macro Economic Scenario
5. Global Automated Compounding Devices Market Size and Growth
.
.
.
32. Global Automated Compounding Devices Market Competitive Benchmarking
33. Global Automated Compounding Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Automated Compounding Devices Market
35. Automated Compounding Devices Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model